Guard Therapeutics International AB (OSTO:GUARD) Dividends per Share: kr0.00 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:GUARD Guard Therapeutics International AB OSTO:GUARD
25 GF Score
Price kr1.50
! 1 Warning Sign
View Full Analysis

What is Guard Therapeutics International AB Dividends per Share?

Guard Therapeutics International AB OSTO:GUARD +7.14% 25 Dividends per Share is kr0.00 as of Mar. 2026. GuruFocus rates OSTO:GUARD with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

Guard Therapeutics International AB's dividends per share for the three months ended in Mar. 2026 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Guard Therapeutics International AB's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Guard Therapeutics International AB  (OSTO:GUARD) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Guard Therapeutics International AB's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ -0.31
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guard Therapeutics International AB Dividends per Share Related Terms

Guard Therapeutics International AB Dividends per Share Historical Data

* Premium members only.

The historical data trend for Guard Therapeutics International AB's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guard Therapeutics International AB Dividends per Share Chart

Guard Therapeutics International AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Guard Therapeutics International AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSTO:GUARD vs VRTX, REGN, ALNY: Dividends per Share Comparison

For the Biotechnology subindustry, Guard Therapeutics International AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guard Therapeutics International AB Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guard Therapeutics International AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Guard Therapeutics International AB's Dividend Yield % falls into.


OSTO:GUARD
25GF Score
Guard Therapeutics International AB OSTO:GUARD
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guard Therapeutics International AB Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of kr0.00 mean?
Guard Therapeutics International AB (OSTO:GUARD) has a Dividends per Share of kr0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Guard Therapeutics International AB and its competitors.
Is Guard Therapeutics International AB's Dividends per Share too high?
Guard Therapeutics International AB's current Dividends per Share is kr0.00. Overall, Guard Therapeutics International AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Guard Therapeutics International AB's Dividends per Share compare to VRTX and REGN?
Guard Therapeutics International AB's Dividends per Share of kr0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Guard Therapeutics International AB and its competitors. Guard Therapeutics International AB's current Dividends per Share is kr0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guard Therapeutics International AB stock overvalued right now?
Guard Therapeutics International AB (OSTO:GUARD) has a current Dividends per Share of kr0.00. The current Dividends per Share is kr0.00. Guard Therapeutics International AB's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Guard Therapeutics International AB (OSTO:GUARD), the current Dividends per Share is kr0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guard Therapeutics International AB Business Description

Address Scheelevagen 22, Lund, SWE, 223 63
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.
25GF Score

Get the complete analysis for OSTO:GUARD

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.50
Price